Brain–Computer Interfaces: The Dawn of a New Era in Disease Treatment
Exploration · 2026-06 · 6 (3)
DOI: 10.1002/exp.20250452 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Exploration, online erschienen am 28.05.2026. Verfasst von Yuqi Feng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Anesthesiology Changhai Hospital Naval Medical University Shanghai China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 360 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Brain–computer interface (BCI) technology has emerged as a crucial interdisciplinary advancement in the field of neuropsychiatric disease treatment. With the global rise in the prevalence of neurological and psychiatric disorders, which impose a substantial burden on society, BCI offers a novel approach. Since the discovery of bioelectric phenomena in the 19th century, various classification frameworks have been developed based on signal paradigms, invasiveness, and feedback mechanisms. BCI applications span multiple disease areas. In movement disorders, it aids in restoring motor function through prosthetic control, functional electrical stimulation, and brain stimulation–based therapies. For patients with communication barriers, it enables alternative communication methods and speech‐related neural signal decoding. In psychiatric conditions, BCI shows growing potential in both diagnosis and treatment, particularly in conditions like autism and depression. Despite significant progress, BCI faces challenges. The long‐term biocompatibility of electrodes and the resolution of neural signals remain to be improved. To address these limitations, research on new electrode materials, such as carbon nanomaterials and composites, is ongoing. Emerging BCI technologies, including endovascular BCI and optogenetics BCI, present new possibilities. The integration of multimodal technologies and artificial intelligence in BCI systems is expected to enhance performance and enable more personalized treatment. Overall, BCI technology holds great promise for improving the quality of life of patients with neuropsychiatric disorders and driving innovation in the medical and neuroscience fields.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Anesthesiology Changhai Hospital Naval Medical University Shanghai China.
- Basic Medical University Naval Medical University Shanghai China.
- School of Anesthesiology Naval Medical University Shanghai China.
- Beijing Institute of Basic Medical Sciences Beijing China.
- Fujian Key Laboratory of Toxicant and Drug Toxicology Medical College Ningde Normal University Ningde China.
- Department of Plastic and Reconstructive Surgery Shanghai Ninth People's Hospital Shanghai JiaoTong University School of Medicine Shanghai China.
ORCID-Profile: Changli Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Feng, Y., Zhang, W., Chen, J., Wu, H., Wu, L., Qiu, Y., Deng, X., Zhu, C., Chen, Y., Zhao, Z., Wang, C., & Zhang, X. (2026). Brain–Computer Interfaces: The Dawn of a New Era in Disease Treatment. Exploration, 6(3). https://doi.org/10.1002/exp.20250452
Vancouver
Feng Y, Zhang W, Chen J, Wu H, Wu L, Qiu Y, et al. Brain–Computer Interfaces: The Dawn of a New Era in Disease Treatment. Exploration. 2026;6(3). doi:10.1002/exp.20250452
BibTeX
@article{Feng2026,
author = {Feng, Yuqi and Zhang, Wangzheqi and Chen, Jun and Wu, Huang and Wu, Lei and Qiu, Yanhao and Deng, Xiaoming and Zhu, Chenglong and Chen, Yisheng and Zhao, Zhijie and Wang, Changli and Zhang, Xiaomin},
title = {Brain–Computer Interfaces: The Dawn of a New Era in Disease Treatment},
journal = {Exploration},
year = {2026},
volume = {6},
number = {3},
doi = {10.1002/exp.20250452}
}
EUVIMED